Veterinary Molecular Diagnostic Market to Grow with a CAGR of 8.65% through 2029
Increasing
companion animal ownership is expected to drive the Global Veterinary Molecular
Diagnostic Market growth in the forecast period, 2025-2029.
According
to TechSci Research report, “Veterinary Molecular Diagnostic Market – Global
Industry Size, Share, Trends, Competition Forecast & Opportunities,
2029F”, the Global Veterinary Molecular Diagnostic Market stood at USD 0.48
billion in 2023 and is anticipated to grow with a CAGR of 8.65% in the forecast
period through 2029. Zoonotic diseases, which can be transmitted between animals
and humans, are a growing public health concern worldwide. Examples include
rabies, Lyme disease, and salmonellosis. Veterinary molecular diagnostics play
a vital role in surveillance and monitoring efforts to detect zoonotic
pathogens in animal populations. The growing prevalence of zoonotic diseases is
a significant driver contributing to the expansion of the Global Veterinary
Molecular Diagnostics Market. Zoonotic diseases are those that can be
transmitted between animals and humans, posing substantial public health risks.
Examples include rabies, Lyme disease, salmonellosis, and avian influenza. As
these diseases continue to emerge and evolve, there is an increased awareness
of the importance of surveillance, early detection, and control measures to mitigate
their impact on both animal and human populations. Veterinary molecular
diagnostics play a crucial role in addressing the challenges posed by zoonotic
diseases by enabling rapid and accurate detection of pathogens in animal
reservoirs. By identifying infected animals and monitoring disease prevalence
in wildlife and domestic species, molecular diagnostic techniques such as
Polymerase Chain Reaction (PCR), sequencing, and microarray analysis facilitate
early intervention and control efforts. Timely detection of zoonotic pathogens
in animal populations is essential for preventing spillover events and
minimizing the risk of transmission to humans.
The
increasing global incidence of zoonotic diseases has also heightened the demand
for advanced diagnostic tools capable of detecting emerging pathogens and
characterizing their genetic diversity. Molecular diagnostics offer superior
sensitivity, specificity, and speed compared to traditional methods, making
them indispensable tools for zoonotic disease surveillance and outbreak
response. Furthermore, the economic burden associated with zoonotic diseases,
including healthcare costs, loss of productivity, and trade restrictions,
further drives the demand for effective diagnostic solutions. By enabling early
detection and intervention, veterinary molecular diagnostics help mitigate the
economic impacts of zoonotic disease outbreaks on both animal agriculture and
public health systems..
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC on
"Global Veterinary Molecular Diagnostic Market”
The
Global Veterinary Molecular Diagnostic market is segmented into product, technology,
application, regional distribution, and company.
Based on technology,
Polymerase Chain Reaction (PCR) technology is expected to continue its
dominance among the PCR, Microarray, and DNA Sequencing segments. PCR's
unparalleled sensitivity, specificity, and versatility in detecting nucleic
acid sequences from various sample types have cemented its position as the
cornerstone of veterinary molecular diagnostics. PCR's widespread adoption
across veterinary clinics, diagnostic laboratories, and research institutions
globally is a key driver of its dominance. Its capability to amplify and detect
target DNA or RNA sequences with high precision has rendered it indispensable
for diagnosing infectious diseases, genetic disorders, and other conditions in
animals. Furthermore, the continuous advancements in PCR techniques, such as
real-time PCR and digital PCR, have broadened its applications and enhanced its
performance, reinforcing its status in the market. Real-time
PCR enables the quantification of target nucleic acids during the amplification
process, offering rapid and accurate results. Digital PCR further enhances
sensitivity and precision by partitioning samples into thousands of individual
reactions, allowing absolute quantification of nucleic acids without the need
for a standard curve.The versatility of PCR extends to its ability to detect
multiple pathogens simultaneously, making it particularly valuable in
diagnosing complex infections or monitoring disease outbreaks. PCR-based assays can be easily customized to target specific pathogens or
genetic mutations, providing tailored solutions for veterinary diagnostic
needs..
Based on te region, Following
North America, the Asia-Pacific region is anticipated to emerge as the dominant
player in the Global Veterinary Molecular Diagnostics Market during the
forecast period. This growth is driven by several factors, including the
increasing adoption of advanced veterinary diagnostic technologies, rising pet
ownership, and significant investments in veterinary healthcare infrastructure. Growing awareness about animal health and the increasing
prevalence of zoonotic diseases in countries like China, India, and Japan are
contributing to the market's expansion. Government initiatives supporting
animal health and the presence of a large livestock population further enhance
the region's potential. With the rapid economic growth and improving healthcare
standards in the Asia-Pacific, the veterinary molecular diagnostics market is
expected to experience substantial growth, positioning the region as a key
player in the global landscape.
Major
companies operating in Global Veterinary Molecular Diagnostic Market are:
- Biochek BV
- Biomerieux SA
- Bioneer Corporation
- Idexx Laboratories
Inc.
- Ingenetix GmbH
- Neogen Corporation
- Thermo Fischer
Scientific Inc.
- Veterinary
Molecular Diagnostics Inc.
- Biomedica
Medizinprodukte GmbH
- Novacyt Group
Download Free Sample Report
Customers
can also request for 10% free customization on this report
“The
Global Veterinary Molecular Diagnostic Market is poised for significant growth
in the coming years. Continuous innovations in assay technologies are
revolutionizing veterinary molecular diagnostics, expanding its capabilities to
new heights. Multiplex PCR assays, for instance, allow simultaneous detection
of multiple pathogens in a single reaction, streamlining the diagnostic process
and conserving precious sample material. Next-generation sequencing (NGS)
enables comprehensive genetic analysis, facilitating the identification of
genetic variations associated with diseases and aiding in personalized treatment
strategies for animals. Digital PCR technology offers precise
quantification of nucleic acids, providing accurate measurements even for
low-abundance targets, which is particularly valuable in detecting early stages
of infections or monitoring treatment efficacy”, said Mr. Karan Chechi,
Research Director of TechSci Research, a research-based management consulting
firm.
“Veterinary
Molecular Diagnostic Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, Segmented By Product (Instruments, Kit and Reagents, Software and
Services), By Application (Infectious Diseases, Genetics, Other), By Technology
(PCR, Microarray, DNA Sequencing), By Region and Competition,2019-2029F”,
has evaluated the future growth potential of Global Veterinary Molecular
Diagnostic Market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global Veterinary Molecular
Diagnostic Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com